Epstein Secrets

480603 Sender Recioienl Senice Two Feder Pnenty OyernigN Package Typo FedEx Envelope Zane 6 Pieces 1 Weight 0 Delivered Aug 06. 20020944 SARAH KLLEN JEFFREY E EPSTEIN 457 MADISON AVE NEW YORK NY 10022.6843 US Transportation Charge 16.00 Seance DiscouM -Z56 Area Code M Fuel Surcharge 0.27

charge o4 2.50%to 0sSthernaa ist attempt Aug 03. 2°02' Delivery &IWO by situations beyond eve CCnkel. Delano: Based Pricing. Zone 4 incerneiShip Venter Traciang 10 790007677834 Service Type FadEx Standard Overnight Package Type FadEx Envelope Zone 4 JEFFREY E EPSTEIN 457 MADISON AVE NEW YORK

ation of Independence, which continues to tour. Mr. Lear is married to Lyn Davis Lear and resides in Los Angeles, California. He has six children: Ellen, Kate, Maggie, Benjamin, Brianna, Madeline and four grandchildren: Daniel, Noah, Griffin, Zoe. EFTA00315150 YO-Y0 MA Yo-Yo Ma's multi-faceted ca

icated to human, microbial, plant, synthetic and environmental genomic research, and the exploration of social and ethical issues in genomics. Dr. Venter is also Founder and CEO of Synthetic Genomics Inc (Sal), a privately held company dedicated to commercializing genomic-driven solutions to address

andmark 1989 album, Back On The Block— named “Album Of The Year” at the 1990 Grammy Awards— brought such legends as Dizzy Gillespie, Ella Fitzgerald, Sarah Vaughan and Miles Davis together with Ice T, Big Daddy Kane and Melle Mel to create the first fusion of the be bop and hip hop musical traditions; wh

aration of Independence, which continues to tour. Mr. Lear is married to Lyn Davis Lear and resides in Los Angeles, California. He has six children: Ellen, Kate, Maggie, Benjamin, Brianna, Madeline and four grandchildren: Daniel, Noah, Griffin, Zoe. HOUSE_OVERSIGHT_017548 --- PAGE BREAK --- YO-YO MA

edicated to human, microbial, plant, synthetic and environmental genomic research, and the exploration of social and ethical issues in genomics. Dr. Venter is also Founder and CEO of Synthetic Genomics Inc (SGI), a privately held company dedicated to commercializing genomic-driven solutions to address gl